{
  "id": "mhgap#risk_safety_c4e610f8",
  "content": "should be avoided and valproate or carbamazepine should\nimprovement, see Follow-up and Table 4. be considered. Erratic compliance or stopping lithium benzodiazepine such as diazepam.\nMonitor weight, blood pressure, fasting sugar, cholesterol and treatment suddenly may increase the risk of relapse. Do not – Benzodiazepines should be discontinued gradually as soon\nECG for persons on antipsychotics if possible (see below). prescribe lithium where the lithium supply may be frequently as symptoms improve, as tolerance can develop.\ninterrupted. Obtain kidney and thyroid function, complete\nblood count, ECG, and pregnancy tests before beginning Continue maintenance treatment for at least 2 years\nCAUTION! treatment if possible. after the last bipolar episode.\nSide effects to look for:\nValproate and Carbamazepine: Consider these – Lithium or valproate can be offered for the maintenance\nMANI CO– L EAxRt rDaIpSOyrRaDmEidal side effects (EPS): akathisia, acute medications if clinical or laboratory monitoring for lithium is treatment of bipolar disorder. If treatment with one of\ndystonic reactions, tremor, cog- wheeling, muscular rigidity, not available or if specialist is not available to supervise these agents is not feasible, haloperidol, chloropromazine\nand tardive dyskinesia. Treat with anticholinergic medications\nlithium prescription. or carbamazepine may be used. Offer maintenance",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "risk_safety",
      "screening_cues",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General — Risk Safety should be avoided and valproate or carbamazepine should\nimprovement, see Follow-up and Table 4. be considered. Erratic compliance or stopping lithium benzodiazepine such as diazepam.\nMonitor weight, blood pressure, fasting sugar, cholesterol and treatment suddenly may increase the risk of relapse. Do not – Benzodiazepines should be discontinued gradually as soon\nECG for persons on antipsychotics if possible (see below). prescribe lithium where the lithium supply may be frequently as symptoms improve, as tolerance can develop.\ninterrupted. Obtain kidney and thyroid function, complete\nblood count, ECG, and pregnancy tests before beginning Continue maintenance treatment for at least 2 years\nCAUTION! treatment if possible. after the last bipolar episode.\nSide effects to look for:\nValproate and Carbamazepine: Consider these – Lithium or valproate can be offered for the maintenance\nMANI CO– L EAxRt rDaIpSOyrRaDmEidal side effects (EPS): akathisia, acute medications if clinical or laboratory monitoring for lithium is treatment of bipolar disorder. If treatment with one of\ndystonic reactions, tremor, cog- wheeling, muscular rigidity, not available or if specialist is not available to supervise these agents is not feasible, haloperidol, chloropromazine\nand tardive dyskinesia. Treat with anticholinergic medications\nlithium prescription. or carbamazepine may be used. Offer maintenance Should be avoided and valproate or carbamazepine should\nimprovement, see follow-up and table 4. be considered."
}